Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia

Haematologica

Volumn 86, Issue 12, 2001, Pages 1254-1260

  Marin C ^a   Martinez Delgado B ^a   Melendez B ^a   Larrayoz, M J ^a   Martinez Ramirez A ^a   Robledo, M ^a   Cigudosa, J C ^a   Calasanz, M J ^a   Benitez J ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

ALL; Genescan analysis; Multiplex PCR; Translocations

Indexed keywords

ACCURACY; ACUTE LYMPHOBLASTIC LEUKEMIA; AGAR GEL ELECTROPHORESIS; ARTICLE; CHIMERA; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 4; CHROMOSOME 9; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPE; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PROGNOSIS; RELIABILITY; SCREENING TEST; VALIDATION PROCESS;

CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRANSLOCATION, GENETIC;

EID: 0035666434     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Molecular genetics of ALL
2. Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia
3. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study
4. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)
5. Immunologic, cytogenetic, and clinical characterization of chilhood acute lymphoblastic leukemia with the t(1;19)(q23; p13) or its derivative
6. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
7. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome
8. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
9. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias
10. Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system
11. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
12. Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization
13. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders
14. Multiplex PCR of bcr-abl fusion transcripts in Philadelphia positive acute lymphoblastic leukemia
15. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis
16. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of the 29 translocations and chomosomal aberrations in acute leukemia
17. A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying translocations of pediatric acute lymphoblastic leukemia
18. Multiplex PCR: A rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia
19. Detection of prognostic significant translocations in childhood acute lymphoblastic leukemia by one-step multiplex reverse transcription polymerase chain reaction
20. Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia
21. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia
22. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia
23. Molecular diagnosis and monitoring of ALL: Applications and limitations